Renalytix PLC
LSE:RENX
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
UK |
Renalytix PLC
LSE:RENX
|
29m GBP | -142.4 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
34.1B USD | 16.2 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.7 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 1.4 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
12.5B AUD | 145.8 | ||
JP |
M3 Inc
TSE:2413
|
1.2T JPY | 3.8 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | 21.4 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 12.9 | ||
SE |
Sectra AB
STO:SECT B
|
45.5B SEK | 22 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 12.1 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | 3.2 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.